OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 13, 2007
An industry survey finds that pharma's outsourcing practices keep the industry from reaping the full benefits of outsourcing.
Although North America accounts for the largest share of the pharmaceutical market, Brazil, China, India, Indonesia, Mexico, Russia, and Turkey are projected to account for almost one-fifth of the global market by 2020. The rising participation in select countries' drug-development activities is evident by recent investment and outsourcing by the pharmaceutical majors.
July 02, 2007
July 01, 2007
Driven by a rapidly ageing population and a known high consumption of pharmaceuticals, the French pharmaceutical market has always appeared buoyant.
June 22, 2007
While some companies float with the tide, others grab market share while business is good.
June 02, 2007
Pharma companies and CMOs build positions in mAbs.
May 30, 2007
Preferred models for clinical and nonclinical services move in opposite directions.
May 02, 2007
May 01, 2007
The more experienced contract manufacturers go far beyond superficial process improvements, drawing on their own expertise and resources to improve the service, value and flexibility they offer their clients.